IL-22 Antagonist Mouse

Interleukin-22 Antagonist (E117A) Mouse Recombinant
Cat. No.
BT12611
Source
Escherichia Coli.
Synonyms
IL-TIF, TIFa, IL-10-related T-cell-derived-inducible factor, IL-22, ILTIF, IL-D110, zcyto18, MGC79382, MGC79384, TIFIL-23.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Purity
Greater than 98.0% as determined by:
(a) Gel filtration chromatography under non-denaturing conditions.
(b) Analysis by reducing and non-reducing SDS-PAGE Silver Stained gel.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Interleukin-22 Antagonist Mouse Recombinant produced in E.Coli is a single, non-glycosylated homodimeric polypeptide chain containing 147 amino acids and having a total molecular mass of 16.7 KDa. The Mouse IL-22 Antagonist is purified by proprietary chromatographic techniques.

Product Specs

Introduction
IL-22, a cytokine within the IL-10 family, shares partial amino acid sequence homology but exhibits distinct biological functions compared to other family members. Primarily produced by T lymphocytes, IL-22 acts as a regulator by suppressing IL-4 production from Th2 cells while stimulating the production of acute phase reactants in the liver and pancreas. The signaling pathway of IL-22 involves a receptor system comprising IL-10R-beta/CRF2-4 and IL-22R, both classified as members of the class II cytokine-receptor family.
Description
Recombinantly produced in E. coli, Interleukin-22 Antagonist Mouse is a non-glycosylated homodimeric polypeptide chain. It consists of 147 amino acids, resulting in a molecular weight of 16.7 KDa. The purification process involves proprietary chromatographic techniques.
Physical Appearance
White lyophilized powder that has been sterilized by filtration.
Formulation
IL-22 Antagonist Mouse is provided in a lyophilized form, prepared from a concentrated solution (1mg/ml) in water containing sodium bicarbonate (NaHCO3).
Solubility
For reconstitution, dissolve the lyophilized Interleukin-22 in sterile 18MΩ-cm H2O at a concentration of at least 100µg/ml. Further dilutions can be made using other aqueous solutions.
Stability
While the lyophilized Interleukin-22 Mouse Antagonist remains stable at room temperature for up to 3 weeks, it is recommended to store it desiccated below -18°C. After reconstitution, store IL22 Antagonist at 4°C for a period of 2-7 days. For long-term storage, keep it below -18°C. Avoid repeated freeze-thaw cycles.
Purity
The purity is determined to be greater than 98.0% using the following methods:
(a) Gel filtration chromatography under non-denaturing conditions.
(b) Analysis by reducing and non-reducing SDS-PAGE, followed by silver staining.
Biological Activity
The IL-22 E117A mutant exhibits full inhibitory activity against STAT3 phosphorylation induced by mouse interleukin 22 in HepG cells. Its binding affinity to immobilized mIL-22 receptor a1 extracellular domain (mIL-22 Ra1-ECD) or IL-22 binding protein is comparable to that of the non-mutated mouse interleukin 22. Notably, Mouse IL-22 antagonist (E117A) demonstrates minimal agonistic activity in this bioassay.
Synonyms
IL-TIF, TIFa, IL-10-related T-cell-derived-inducible factor, IL-22, ILTIF, IL-D110, zcyto18, MGC79382, MGC79384, TIFIL-23.
Source
Escherichia Coli.
Amino Acid Sequence
The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Leu-Pro-Val-Asn.

Product Science Overview

Introduction

Interleukin-22 (IL-22) is a member of the IL-10 family of regulatory cytokines. These cytokines share partial homology in their amino acid sequences but differ significantly in their biological functions. IL-22 is primarily produced by T lymphocytes and plays a crucial role in immune responses, particularly in the regulation of inflammatory processes. It inhibits IL-4 production by Th2 cells and induces acute phase reactants in the liver and pancreas .

Structure and Production

The Interleukin-22 Antagonist (E117A) (Mouse Recombinant) is a mutant form of IL-22. It is produced in Escherichia coli (E. coli) and is a single, non-glycosylated homodimeric polypeptide chain containing 147 amino acids, with a total molecular mass of 16.7 kDa . The E117A mutation refers to the substitution of glutamic acid (E) at position 117 with alanine (A), which significantly alters its biological activity.

Biological Activity

The E117A mutant of IL-22 is capable of fully inhibiting the phosphorylation of STAT3 induced by mouse IL-22 in HepG cells. Its affinity towards the immobilized mouse IL-22 receptor a1 extracellular domain (mIL-22 Ra1-ECD) or IL-22 binding protein is similar to that of the non-mutated mouse IL-22 . This antagonist has very low agonistic activity, making it an effective inhibitor in various biological assays.

Preparation and Stability

The recombinant IL-22 antagonist is purified using proprietary chromatographic techniques to ensure high purity. It is lyophilized from a concentrated solution in water containing sodium bicarbonate (NaHCO3) and is recommended to be reconstituted in sterile water to a concentration of not less than 100 µg/ml . The lyophilized form is stable at room temperature for up to three weeks but should be stored desiccated below -18°C for long-term storage. Upon reconstitution, it should be stored at 4°C for short-term use and below -18°C for future use, avoiding freeze-thaw cycles .

Applications

The IL-22 antagonist (E117A) is primarily used in laboratory research to study the role of IL-22 in various biological processes and diseases. It is particularly useful in investigating the signaling pathways involving IL-22 and its receptors, as well as in developing potential therapeutic strategies for conditions characterized by excessive IL-22 activity.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.